文献速递泌尿生殖与妇科肿瘤放疗放疗物理与技术

前列腺癌常规与大分割放疗后急性直肠炎的放射生物学模型

Radiobiological Modeling for Acute Proctitis After Conventional and Hypofractionated Radiation Therapy for Prostate Cancer.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2025-10-23

基于两项前瞻性研究321例前列腺癌患者数据,建立固定4周治疗时间内急性直肠炎的正常组织并发症概率模型,纳入等效均匀剂量和雄激素剥夺治疗作为预测因子,模型区分度良好,并显示治疗时间延长1周可降低并发症概率。

要点

  • 急性直肠炎发生率在20次3.0/3.1 Gy组为66%,20次2 Gy组为25%,12次3.4 Gy组为24%。
  • 模型以等效均匀剂量(BED)和雄激素剥夺治疗为预测因子,曲线下面积0.77。
  • 治疗时间延长1周,急性直肠炎概率估计降低4%至20%。

核心结论

  • 建立了性能良好的急性直肠炎NTCP模型,以等效均匀剂量和雄激素剥夺治疗为预测因子,适用于常规和大分割方案。

研究设计与样本

  • 从两项前瞻性研究选取321例接受前列腺±精囊放疗的患者,分析固定4周治疗时间内的急性直肠炎。
  • 基于7项患者报告症状评分急性直肠炎,拟合3个逻辑回归模型,采用最大似然估计参数,并用自举法内部验证。

主要发现

  • 急性直肠炎发生率在20次3.0/3.1 Gy组为66%,20次2 Gy组为25%,12次3.4 Gy组为24%。
  • 模型_10Gy含等效均匀剂量(n=0.30,95%CI 0.15至0.45)和雄激素剥夺治疗(OR 0.61),曲线下面积0.77。
  • 模型_α/β估计α/β为17 Gy(95%CI 6至>20 Gy),性能相似。
  • 模型_TT估计治疗时间延长1周,急性直肠炎概率降低4%至20%。

关键数值与推荐

  • 模型_10Gy假设α/β=10 Gy,等效均匀剂量体积参数n=0.30(95%CI 0.15至0.45),雄激素剥夺治疗OR=0.61,曲线下面积0.77。
  • 模型_α/β估计α/β=17 Gy(95%CI 6至>20 Gy)。
  • 模型_TT估计治疗时间延长1周,NTCP降低4%至20%。

临床怎么用

  • 该模型可用于预测前列腺癌常规和大分割放疗后固定4周时的急性直肠炎风险,辅助临床决策。
  • 治疗时间延长可能降低急性直肠炎风险,但需结合其他因素综合评估。

局限性

  • 研究仅关注固定4周治疗时间内的观察毒性,未覆盖整个急性期。
  • 模型基于两项前瞻性研究数据,需外部验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Acute proctitis (AP) is a common side effect of pelvic radiation therapy. Randomized studies showed increased risks after moderate hypofractionated radiation therapy with shorter overall treatment times (TTs). We developed normal tissue complication probability (NTCP) models for AP for a fixed TT of 4 weeks (W4), based on combined dose-fractionation data. METHODS AND MATERIALS: Study patients treated with 20 fractions of 3.0/3.1 Gy, 39 fractions of 2 Gy (both 5 fractions/wk) or 19 fractions of 3.4 Gy (3 fractions/wk) to prostate ± vesicles were selected from 2 prospective studies (n = 321). We focused on observed toxicity in W4 (not the total acute period). Patient-reported symptoms and delivered dose data at W4 were collected (20 × 3.0/3.1 Gy, 20 × 2 Gy, 12 × 3.4 Gy). AP was scored based on 7 patient-reported symptoms (e.g. mucus loss). We fitted 3 logistic regression models based on the equivalent uniform dose (EUD) in biologically effective dose (BED) with diabetes and androgen deprivation therapy (ADT) as candidate clinical predictors. The EUD volume parameter, n, was estimated with maximum likelihood estimation (MLE). In model_10Gy, we assumed α/β = 10 Gy, whereas in model_α/β, α/β was estimated with MLE together with n. In model_TT, the impact of TT on NTCP was explored using Fowler's BED formula with TT correction. Backward elimination was applied for parameter selection and bootstrapping for internal validation. RESULTS: AP incidence was 66%, 25%, and 24% after 20 × 3.0/3.1 Gy, 20 × 2 Gy, and 12 × 3.4 Gy, respectively. Model_10Gy contained EUD with n = 0.30 (95% confidence interval [CI], 0.15 to 0.45), and ADT (OR, 0.61) as predictors, with an area under the curve of 0.77. Model_α/β showed similar performance with an estimated α/β of 17 Gy (95% CI, 6 to >20 Gy). Model_TT estimated NTCP reductions of 4% to 20% when TT is extended by 1 week. CONCLUSIONS: We developed well-performing NTCP models for AP as a function of EUD and ADT and showed a good fit for the commonly assumed α/β of 10 Gy, and for both conventional and moderate hypofractionated schemes.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Jongen CAM, Heijmen BJM, Incrocci L, et al. Radiobiological Modeling for Acute Proctitis After Conventional and Hypofractionated Radiation Therapy for Prostate Cancer. Int J Radiat Oncol Biol Phys. 2025. PMID: 41138787. doi:10.1016/j.ijrobp.2025.10.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。